KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Accured Expenses (2016 - 2019)

Historic Change in Accured Expenses for Thermo Fisher Scientific (TMO) over the last 11 years, with Q4 2019 value amounting to $38.0 million.

  • Thermo Fisher Scientific's Change in Accured Expenses fell 7579.62% to $38.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $210.0 million, marking a year-over-year increase of 60000.0%. This contributed to the annual value of $210.0 million for FY2019, which is 60000.0% up from last year.
  • According to the latest figures from Q4 2019, Thermo Fisher Scientific's Change in Accured Expenses is $38.0 million, which was down 7579.62% from -$147.0 million recorded in Q3 2019.
  • Thermo Fisher Scientific's Change in Accured Expenses' 5-year high stood at $992.0 million during Q4 2017, with a 5-year trough of -$471.0 million in Q1 2018.
  • In the last 5 years, Thermo Fisher Scientific's Change in Accured Expenses had a median value of $115.2 million in 2015 and averaged $80.0 million.
  • Within the past 5 years, the most significant YoY rise in Thermo Fisher Scientific's Change in Accured Expenses was 1201944.44% (2015), while the steepest drop was 24797.9% (2015).
  • Thermo Fisher Scientific's Change in Accured Expenses (Quarter) stood at $436.3 million in 2015, then fell by 16.89% to $362.6 million in 2016, then soared by 173.58% to $992.0 million in 2017, then crashed by 84.17% to $157.0 million in 2018, then tumbled by 75.8% to $38.0 million in 2019.
  • Its last three reported values are $38.0 million in Q4 2019, -$147.0 million for Q3 2019, and $549.0 million during Q2 2019.